Aditum Bio Management Company, LLC
Aditum Bio Fund 2, L.P.
Follow-ons onlyEmerging manager
Follow-ons only: no first sale reported; age from Form D filed Jul 2021 (approximate)
- Vintage
- Unknown
- Fund size
- $250M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$2.5M to $4.17M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Mark Fishman
- Joe Jimenez
- Praveena Kandula, Managing Director of the General Partner of the Issuer
- Ilan Zipkin, Managing Director of the General Partner of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Aditum Bio invests in translational-stage drug development using its agile operating model for company formation and trial execution.
FUND II Launched: 2021
https://www.aditumbio.com/portfolio
06 · Sources
Last verified: Oct 28, 2026